PF-Atlas › Clinical Trials › NCT06437210
Evaluation of Treatment With Viusid in Post-COVID-19 Syndrome
Viusid Oral Solution · Not specified
Registry ID
NCT06437210
Phase
Not specified
Status
Completed
Drug / intervention
Viusid Oral Solution
Sponsor
Catalysis SL
Start
2022-02-15
About this trial
Viusid Oral Solution is evaluated in NCT06437210, a idiopathic pulmonary fibrosis study sponsored by Catalysis SL. Current status: Completed.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT06437210 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.